Get Live Data

Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globallyView Video
Firering Strategic Minerals : from explorer to producer
Firering Strategic Minerals: From explorer to producerView Video

Latest Share Chat

  2. Share Prices
  3. Avacta Group Share Price
  4. Avacta Group Share News
  5. IN BRIEF: Avacta to sell Covid-19 test in UK in "coming days"

Pin to quick picksAvacta Group Share News (AVCT)

Avacta Group Information

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 46.25
Bid: 45.50
Ask: 47.00
Change: 1.75 (3.83%)
Spread: 1.50 (3.297%)
Open: 45.75
High: 47.50
Low: 47.50
Prev. Close: 45.75
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Avacta to sell Covid-19 test in UK in "coming days"

Mon, 10th May 2021 11:13

Avacta Group PLC - Yorkshire-based drug and diagnostic equipment developer - Submits declaration of conformity for rapid Covid-19 lateral flow test to the UK's Medicines & Healthcare Products Regulatory Agency. Expects registration of test to be confirmed in the coming days, before it is immediately placed on the market. The test has been shown to be more sensitive than lateral flow tests currently on the market, particularly for lower viral loads.

Current stock price: 266.88 pence, up 1.9% on Monday

Year-to-date change: more than doubled from 114.0p on December 31

By Ivan Edwards; ivanedwards@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
23 Nov 2020 15:20

Avacta reports 'significant progress' on Covid-19 test

(Sharecast News) - Cancer therapies and diagnostics developer Avacta Group announced "significant progress" in the development of a scalable manufacturing process for a lateral flow SARS-CoV-2 antigen test being carried out with BBI Solutions on Monday.

Read more
22 Oct 2020 15:53

UK DIRECTOR DEALINGS SUMMARY: Dunkerton Buys More Superdry Shares

UK DIRECTOR DEALINGS SUMMARY: Dunkerton Buys More Superdry Shares

Read more
1 Oct 2020 06:40

IN BRIEF: Avacta Stock Continues Rise After Launch Of SARS-CoV-2 Test

IN BRIEF: Avacta Stock Continues Rise After Launch Of SARS-CoV-2 Test

Read more
24 Sep 2020 15:43

UK's Integumen unveils prototype COVID-19 breath test

LONDON, Sept 24 (Reuters) - Integumen, a British company that developed a system to detect the COVID-19 virus in waste water, said the same technology could be deployed in a personalised breath test that could become an effective tool in fighting...

Read more
21 Sep 2020 16:08

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
7 Sep 2020 14:28

IN BRIEF: Avacta To Launch SARS-CoV-2 Elisa Laboratory Test

IN BRIEF: Avacta To Launch SARS-CoV-2 Elisa Laboratory Test

Read more
7 Sep 2020 12:55

Avacta launching Covid-19 laboratory test

(Sharecast News) - Biotherapeutics company Avacta Group announced on Monday that it will launch an 'ELISA' laboratory test for the SARS-CoV-2 spike protein, to support global research efforts into the coronavirus that causes Covid-19.

Read more
2 Sep 2020 15:50

IN BRIEF: Avacta Expands Covid-19 Saliva Test Manufacturing Capacity

IN BRIEF: Avacta Expands Covid-19 Saliva Test Manufacturing Capacity

Read more
2 Sep 2020 13:37

Avacta signs Covid-19 test manufacturing deal with Abingdon

(Sharecast News) - Biotherapeutics company Avacta Group has entered into an agreement with Abingdon Health for the manufacture of its saliva-based rapid SARS-CoV-2 antigen test, it announced on Wednesday, as part of its ongoing expansion of manufacturing capacity.

Read more
18 Aug 2020 10:39

Avacta Expands Development Agreement With LG Chem Life Sciences

Avacta Expands Development Agreement With LG Chem Life Sciences

Read more
17 Aug 2020 20:07

IN BRIEF: Avacta Not Involved With Medusa 19's Covid Antibody Test

IN BRIEF: Avacta Not Involved With Medusa 19's Covid Antibody Test

Read more
11 Aug 2020 14:18

IN BRIEF: Avacta Names New Life Sciences Chief Development Officer

IN BRIEF: Avacta Names New Life Sciences Chief Development Officer

Read more
7 Aug 2020 11:11

Avacta to collaborate with Liverpool School of Tropical Medicine on Covid-19 test

(Sharecast News) - Avacta Group has entered into a collaboration with the Liverpool School of Tropical Medicine (LSTM), it announced on Friday, to clinically validate the rapid saliva-based coronavirus antigen test it is developing with Cytiva.

Read more
7 Aug 2020 10:45

UK WINNERS & LOSERS SUMMARY: Hikma Shines After Raising Sales Guidance

UK WINNERS & LOSERS SUMMARY: Hikma Shines After Raising Sales Guidance

Read more
7 Aug 2020 09:53

Avacta Collaborates With Liverpool School For Covid-19 Test Validation

Avacta Collaborates With Liverpool School For Covid-19 Test Validation

Read more
8910111213141516

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.